dihexa cancer risk hgf c-met Frontiers Recent Progress and Advances in
Recent Progress and Advances in HGF MET Targeted Therapeutic Agents for Cancer Treatment Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect Role of the HGF c MET tyrosine kinase inhibitors in metastasic melanoma Molecular Cancer Springer Nature Link Targeting HGF c MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion Cell Communication and Signaling Springer Nature Link
Pay in 4 interest-free payments of $6.15 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



